Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,608 | -11,095 | -40,420 | -30,199 | -20,339 |
| Depreciation Amortization | 587 | 15 | -103 | 614 | -49 |
| Other Working Capital | -335 | -525 | -3,126 | -3,912 | -5,101 |
| Other Operating Activity | 2,290 | 1,226 | 6,092 | 4,640 | 3,193 |
| Operating Cash Flow | $-18,066 | $-10,379 | $-37,557 | $-28,857 | $-22,296 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -12,186 | -12,186 | -12,186 |
| PPE Investments | -55 | N/A | -45 | -45 | -8 |
| Sale Of Investment | 26,100 | 23,100 | 65,338 | 50,820 | 44,405 |
| Investing Cash Flow | $26,045 | $23,100 | $53,107 | $38,589 | $32,211 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 41,964 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 135 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -83 | -76 | -91 | -91 | -64 |
| Financing Cash Flow | $42,016 | $-76 | $-91 | $-91 | $-64 |
| Beginning Cash Position | 40,331 | 40,331 | 24,872 | 24,872 | 24,872 |
| End Cash Position | 90,326 | 52,976 | 40,331 | 34,513 | 34,723 |
| Net Cash Flow | $49,995 | $12,645 | $15,459 | $9,641 | $9,851 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,066 | -10,379 | -37,557 | -28,857 | -22,296 |
| Capital Expenditure | -55 | 0 | -45 | -45 | -8 |
| Free Cash Flow | -18,121 | -10,379 | -37,602 | -28,902 | -22,304 |